Literature DB >> 19351957

Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques.

Stéphanie Beq1, Sandra Rozlan, David Gautier, Raphaëlle Parker, Véronique Mersseman, Clémentine Schilte, Brigitte Assouline, Iann Rancé, Pascal Lavedan, Michel Morre, Rémi Cheynier.   

Abstract

Interleukin-7 (IL-7), the principal cytokine implicated in thymopoiesis and peripheral T-cell homeostasis, is presently under evaluation in human diseases characterized by persistent lymphopenia. Unexpectedly, before the eventual IL-7-driven T-cell expansion, all treated patients showed a profound T-cell depletion 24 hours after injection. The current study uses the rhesus macaque model to investigate the mechanisms involved in this IL-7-induced T-cell depletion. We identify a new critical function of IL-7 that induces massive and rapid T-cell migration from the blood into various organs, including lymph nodes, parts of the intestine, and the skin. This homing process was initiated after the induction of chemokine receptor expression by circulating T cells and the production of corresponding chemokines in target organs. Finally, we demonstrate that the IL-7-induced cell cycling is initiated within these organs before T cells migrate back into the bloodstream, indicating that T-cell homing is required for in vivo IL-7 function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19351957     DOI: 10.1182/blood-2008-11-191288

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease.

Authors:  Lyssia Belarif; Richard Danger; Laetitia Kermarrec; Véronique Nerrière-Daguin; Sabrina Pengam; Tony Durand; Caroline Mary; Elise Kerdreux; Vanessa Gauttier; Aneta Kucik; Virginie Thepenier; Jerome C Martin; Christie Chang; Adeeb Rahman; Nina Salabert-Le Guen; Cécile Braudeau; Ahmed Abidi; Grégoire David; Florent Malard; Celine Takoudju; Bernard Martinet; Nathalie Gérard; Isabelle Neveu; Michel Neunlist; Emmanuel Coron; Thomas T MacDonald; Pierre Desreumaux; Hoa-Le Mai; Stephanie Le Bas-Bernardet; Jean-François Mosnier; Miriam Merad; Régis Josien; Sophie Brouard; Jean-Paul Soulillou; Gilles Blancho; Arnaud Bourreille; Philippe Naveilhan; Bernard Vanhove; Nicolas Poirier
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

2.  Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses.

Authors:  Amanda Leone; Mukta Rohankhedkar; Afam Okoye; Alfred Legasse; Michael K Axthelm; Francois Villinger; Michael Piatak; Jeffrey D Lifson; Brigitte Assouline; Michel Morre; Louis J Picker; Donald L Sodora
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

3.  Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.

Authors:  Bruno Francois; Robin Jeannet; Thomas Daix; Andrew H Walton; Matthew S Shotwell; Jacqueline Unsinger; Guillaume Monneret; Thomas Rimmelé; Teresa Blood; Michel Morre; Anne Gregoire; Gail A Mayo; Jane Blood; Scott K Durum; Edward R Sherwood; Richard S Hotchkiss
Journal:  JCI Insight       Date:  2018-03-08

4.  Developmental lead effects on behavior and brain gene expression in male and female BALB/cAnNTac mice.

Authors:  Jane Kasten-Jolly; Nina Pabello; Valerie J Bolivar; David A Lawrence
Journal:  Neurotoxicology       Date:  2012-05-16       Impact factor: 4.294

5.  IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis.

Authors:  Jacqueline Unsinger; Margaret McGlynn; Kevin R Kasten; Andrew S Hoekzema; Eizo Watanabe; Jared T Muenzer; Jacquelyn S McDonough; Johannes Tschoep; Thomas A Ferguson; Jonathan E McDunn; Michel Morre; David A Hildeman; Charles C Caldwell; Richard S Hotchkiss
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

6.  Cdc25A-driven proliferation regulates CD62L levels and lymphocyte movement in response to interleukin-7.

Authors:  Christina Kittipatarin; Wenqing Li; Scott K Durum; Annette R Khaled
Journal:  Exp Hematol       Date:  2010-09-08       Impact factor: 3.084

7.  IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa.

Authors:  Raffaello Cimbro; Lia Vassena; James Arthos; Claudia Cicala; John H Kehrl; Chung Park; Irini Sereti; Michael M Lederman; Anthony S Fauci; Paolo Lusso
Journal:  Blood       Date:  2012-08-14       Impact factor: 22.113

8.  Decreased interleukin 7 responsiveness of T lymphocytes in patients with idiopathic CD4 lymphopenia.

Authors:  Camille E Puronen; William L Thompson; Hiromi Imamichi; Stephanie Beq; Jessica N Hodge; Catherine Rehm; Raphaelle Parker; Rebecca DerSimonian; Jason M Brenchley; Irini Sereti
Journal:  J Infect Dis       Date:  2012-03-26       Impact factor: 5.226

9.  Interleukin-7 promotes HIV persistence during antiretroviral therapy.

Authors:  Claire Vandergeeten; Rémi Fromentin; Sandrina DaFonseca; Mariam B Lawani; Irini Sereti; Michael M Lederman; Moti Ramgopal; Jean-Pierre Routy; Rafick-Pierre Sékaly; Nicolas Chomont
Journal:  Blood       Date:  2013-04-15       Impact factor: 22.113

10.  Effect of IL-7 Therapy on Naive and Memory T Cell Homeostasis in Aged Rhesus Macaques.

Authors:  Afam A Okoye; Mukta Rohankhedkar; Audrie L Konfe; Chike O Abana; Matthew D Reyes; Joseph A Clock; Derick M Duell; Andrew W Sylwester; Partha Sammader; Alfred W Legasse; Byung S Park; Michael K Axthelm; Janko Nikolich-Žugich; Louis J Picker
Journal:  J Immunol       Date:  2015-09-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.